Decarbonizing the industry

The demand for goods, equipment, and energy has increased in line with the growth of the global population and the aspiration of most populations to have a high level of comfort and service. This demand is met by an industrialized and globalized production system that heavily relies on hydrocarbons and coal. As a major contributor to greenhouse gas (GHG) emissions, the industry is targeted by policies aimed at reducing carbon footprint caused by human activities. The industry faces a dual challenge: decarbonizing its production processes and transitioning manufacturing towards low-carbon products capable of contributing to the overall GHG emissions reduction.

Romain Allais, one of Artelia’s specialists in industrial decarbonization, presents the several levers currently being activated or considered to drive this change.

Healthcare sovereignty and pharmaceutical manufacturing​

Segens Roussillon aerial view

The Covid-19 pandemic of 2020 revealed the extent to which European nations depend on imports of medicines and the active pharmaceutical ingredients essential to their manufacture. The issue of healthcare sovereignty was thus raised once again at an EU level and a number of member states declared their desire to secure their supplies of medicines, in particular by relocating industrial production and boosting their domestic capabilities. David Papillon, who is overseeing for Artelia the design of the Seqens paracetamol plant in Roussillon (SE France), tells us what he has learned about this new movement taking shape in France.

Soitec Bernin

Extension d’une usine de fabrication de matériaux semi-conducteurs

Manitou Candé

Quality and ergonomic tooling to optimize an assembly line